State Street’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $36M | Buy |
|
|||||
|
2025
Q2 | $25.5M | Sell |
|
|||||
|
2025
Q1 | $46.7M | Sell |
|
|||||
|
2024
Q4 | $75.8M | Buy |
|
|||||
|
2024
Q3 | $129M | Buy |
|
|||||
|
2024
Q2 | $106M | Sell |
|
|||||
|
2024
Q1 | $115M | Buy |
|
|||||
|
2023
Q4 | $90M | Buy |
|
|||||
|
2023
Q3 | $75.1M | Sell |
|
|||||
|
2023
Q2 | $109M | Buy |
|
|||||
|
2023
Q1 | $107M | Sell |
|
|||||
|
2022
Q4 | $72.8M | Buy |
|
|||||
|
2022
Q3 | $88.9M | Sell |
|
|||||
|
2022
Q2 | $87.3M | Buy |
|
|||||
|
2022
Q1 | $106M | Sell |
|
|||||
|
2021
Q4 | $122M | Buy |
|
|||||
|
2021
Q3 | $139M | Buy |
|
|||||
|
2021
Q2 | $125M | Buy |
|
|||||
|
2021
Q1 | $123M | Buy |
|
|||||
|
2020
Q4 | $73.5M | Sell |
|
|||||
|
2020
Q3 | $56.6M | Sell |
|
|||||
|
2020
Q2 | $61M | Buy |
|
|||||
|
2020
Q1 | $58.6M | Buy |
|
|||||
|
2019
Q4 | $106M | Buy |
|
|||||
|
2019
Q3 | $102M | Sell |
|
|||||
|
2019
Q2 | $115M | Buy |
|
|||||
|
2019
Q1 | $135M | Buy |
|
|||||
|
2018
Q4 | $108M | Buy |
|
|||||
|
2018
Q3 | $159M | Buy |
|
|||||
|
2018
Q2 | $117M | Sell |
|
|||||
|
2018
Q1 | $107M | Buy |
|
|||||
|
2017
Q4 | $120M | Buy |
|
|||||
|
2017
Q3 | $112M | Sell |
|
|||||
|
2017
Q2 | $80.3M | Sell |
|
|||||
|
2017
Q1 | $61M | Sell |
|
|||||
|
2016
Q4 | $59.8M | Buy |
|
|||||
|
2016
Q3 | $63.8M | Buy |
|
|||||
|
2016
Q2 | $66.1M | Sell |
|
|||||
|
2016
Q1 | $82.3M | Buy |
|
|||||
|
2015
Q4 | $86.8M | Buy |
|
|||||
|
2015
Q3 | $71.7M | Sell |
|
|||||
|
2015
Q2 | $71.9M | Buy |
|
|||||
|
2015
Q1 | $57.4M | Buy |
|
|||||
|
2014
Q4 | $52M | Buy |
|
|||||
|
2014
Q3 | $58.2M | Sell |
|
|||||
|
2014
Q2 | $64.3M | Sell |
|
|||||
|
2014
Q1 | $60.6M | Sell |
|
|||||
|
2013
Q4 | $41.6M | Sell |
|
|||||
|
2013
Q3 | $50.7M | Buy |
|
|||||
|
2013
Q2 | $48.1M | Buy |
|